Literature DB >> 26585101

Evaluation of cumulative cognitive deficits from electroconvulsive therapy.

George G Kirov1, Laura Owen2, Hazel Ballard2, Adele Leighton2, Kara Hannigan2, Danielle Llewellyn2, Valentina Escott-Price2, Maria Atkins2.   

Abstract

BACKGROUND: Electroconvulsive therapy (ECT) is the most effective acute treatment for severe depression, but widely held concerns about memory problems may limit its use. AIMS: To find out whether repeated or maintenance courses of ECT cause cumulative cognitive deterioration.
METHOD: Analysis of the results of 10 years of cognitive performance data collection from patients who have received ECT. The 199 patients had a total of 498 assessments, undertaken after a mean of 15.3 ECT sessions (range 0-186). A linear mixed-effect regression model was used, testing whether an increasing number of ECT sessions leads to deterioration in performance.
RESULTS: The total number of previous ECT sessions had no effect on cognitive performance. The major factors affecting performance were age, followed by the severity of depression at the time of testing and the number of days since the last ECT session.
CONCLUSIONS: Repeated courses of ECT do not lead to cumulative cognitive deficits. This message is reassuring for patients, carers and prescribers who are concerned about memory problems and confusion during ECT. © The Royal College of Psychiatrists 2016.

Entities:  

Mesh:

Year:  2015        PMID: 26585101     DOI: 10.1192/bjp.bp.114.158261

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  6 in total

1.  Maintenance ECT is associated with sustained improvement in depression symptoms without adverse cognitive effects in a retrospective cohort of 100 patients each receiving 50 or more ECT treatments.

Authors:  James Luccarelli; Thomas H McCoy; Stephen J Seiner; Michael E Henry
Journal:  J Affect Disord       Date:  2020-04-13       Impact factor: 4.839

2.  Relapse after abrupt discontinuation of maintenance electroconvulsive therapy during the COVID-19 pandemic.

Authors:  Simon Lambrichts; Kristof Vansteelandt; Bo Crauwels; Jasmien Obbels; Eva Pilato; Jonas Denduyver; Katrien Ernes; Pieter-Paul Maebe; Charlotte Migchels; Lore Roosen; Satya Buggenhout; Filip Bouckaert; Didier Schrijvers; Pascal Sienaert
Journal:  Acta Psychiatr Scand       Date:  2021-06-28       Impact factor: 7.734

3.  Total Charge Required to Induce a Seizure in a Retrospective Cohort of Patients Undergoing Dose Titration of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy.

Authors:  James Luccarelli; Thomas H McCoy; Stephen J Seiner; Michael E Henry
Journal:  J ECT       Date:  2021-03-01       Impact factor: 3.692

4.  The innate immune system and neurogenesis as modulating mechanisms of electroconvulsive therapy in pre-clinical studies.

Authors:  Juliette Giacobbe; Carmine M Pariante; Alessandra Borsini
Journal:  J Psychopharmacol       Date:  2020-07-10       Impact factor: 4.153

5.  Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study.

Authors:  Lei Zou; Su Min; Qibin Chen; Xiao Li; Li Ren
Journal:  Brain Behav       Date:  2020-12-11       Impact factor: 2.708

6.  Long-term subjective memory after electroconvulsive therapy.

Authors:  Robert Sigström; Axel Nordenskjöld; Anders Juréus; Caitlin Clements; Erik Joas; Erik Pålsson; Mikael Landén
Journal:  BJPsych Open       Date:  2020-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.